Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Darcy Krueger, MD, PhD
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Mustafa Sahin, MD, PhD
Boston Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California at Los Angeles
Los Angeles, California, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- University of Texas at Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 31 Dec 2019
- Completion
- 31 Dec 2020
- Last update posted
- 4 Feb 2021
- Registered enrollment
- 166
- Registry id
- NCT01780441
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.